CRINETICS PHARMACEUTICALS

Live / Registered — Registered (as of 28 Dec 2021)

What this means for you

Registered since 28 Dec 2021. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
87875067
Registration number
6603347
Mark type
Design + words
Filed
12 Apr 2018
Published for opposition
18 Sept 2018
Registered
28 Dec 2021
Attorney of record
Danny M. Awdeh

Goods and services

  • Class 042 — Scientific and technological services: Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of modulating neuropeptides and G-protein coupled receptors (GPCRs); medical research for use in oncology; medical research in the field of pharmacology for treating endocrine disorders and endocrine-related cancers; pharmaceutical research for the purpose of targeting neuropeptide receptors; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others

Owner

Prosecution history

  • 28 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 28 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 28 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 28 Feb 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 28 Feb 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 28 Dec 2021 — REGISTERED-PRINCIPAL REGISTER
  • 20 Nov 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 19 Nov 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 02 Nov 2021 — STATEMENT OF USE PROCESSING COMPLETE
  • 29 Oct 2021 — USE AMENDMENT FILED
  • 29 Oct 2021 — TEAS STATEMENT OF USE RECEIVED
  • 08 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 07 May 2021 — SOU EXTENSION 5 GRANTED
  • 29 Apr 2021 — SOU EXTENSION 5 FILED
  • 07 May 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL

View this trademark record on Marksy